Please Wait...

DIA 2013 Boston Recap from the BioClinica Exhibit

DIA 2013 Boston Recap

What a great time DIA Boston was!

As Director of Clinical Solutions, one of my responsibilities is giving product demonstrations in BioClinica’s exhibit booth. Much of my time during conference hours was spent with my eyes and ears focused on growing my understanding of your needs to run clinical trials more efficiently and cost-effectively.
Below is a recap of hot topics from my vantage in the exhibit hall point where thousands of industry professionals converged to learn new ways to overcome current and future challenges:    

TransCelerate BioPharma
Having recently grown to 16 member companies, TransCelerate is rapidly gaining momentum as the consortium drives toward clinical research change. Two best practice recommendations widely discussed were the use of CDISC SHARE  and Risk Based Monitoring. Check out an earlier blog I wrote about semantic standards including SHARE. To see how TranCelerate plans to assess risk in clinical trials, read the position paper here .

Risk, Managing Risk, Risk-Based Monitoring
Risk was a major theme in multiple areas throughout the conference. Two recent FDA draft guidance documents give pharmaceutical companies the go-ahead for managing risk while making the process of collecting and reviewing study data easier and less costly. Several DIA sessions explored compliance with these documents: Electronic Source Data in Clinical Investigations, Nov. 2012 and Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring, Aug. 2011

My colleagues and I demonstrated how BioClinica’s innovative risk management software can provide significant cost-savings. Missed it? Contact us for a private demo.

Here’s a photo of me drilling down into the data using the big touch screen in the Microsoft exhibit.


A photo of me drilling down into the data using the big touch screen in the Microsoft exhibit.

The Sunshine Act
Many people stopped by and expressed concern about Sunshine Act compliance. Fast-approaching, the Act requires pharmaceutical, medical device, biological, and medical supply manufacturers to report "payment or other transfer of value" to physicians and teaching hospitals. BioClinica’s OnPoint CTMS has a payment module that supports Sunshine Act reporting requirements.

Operational Metrics
Linda Sullivan of the Metrics Champion Consortium (MCC) popped in to thank BioClinica for its support in developing standardized metrics. She also requested assistance with completing MCC’s own Risk-Based Monitoring Industry Survey. This all-volunteer group has assembled recommended standard metrics for multiple areas including Clinical Trials, Central Labs, Imaging, and Cardiopulmonary. Learn about recent milestones.

Many DIA event-goers used myDIAfun.com to find parties, restaurants, and prize opportunities. Based on considerable positive feedback, BioClinica is pleased to offer MyDiaFun for next year’s convention in San Diego.
 

Category: 

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

What's next from Bioclinica? Hear if first during #PCTrials Europe next week in Amsterdam! https://t.co/ICngaxA9mg https://t.co/SXxPj3NpD2
bioclinica (30 minutes ago)
Join Bioclinica's Justin Hunt on Nov. 28 in a live webinar! Find out how to overcome common hurdles in CTMS impleme… https://t.co/wHfWHtI7sj
bioclinica (22 hours ago)
Another CRO seeing big gains in the sites payments process! Access the Case Study here https://t.co/jsCxhmKcLo https://t.co/LpIKEtBKtE
bioclinica (Yesterday)
Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials. https://t.co/OVH7pZ3SL0
bioclinica (Yesterday)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will give a… https://t.co/8ymd2Q9KcJ
bioclinica (Yesterday)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will giv… https://t.co/MpxTDV1T1L
bioclinica (Yesterday)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices